Published in Transplantation on April 01, 1992
The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation (1993) 0.95
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation (1983) 3.60
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION. Surg Res Commun (1987) 3.46
Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29
Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia. Infect Immun (1982) 3.22
The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med (1975) 3.09
Cytomegalic inclusion disease in adults. Report of 14 cases with review of literature. Arch Pathol (1962) 2.80
Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis (1988) 2.76
Cytomegalovirus infection in the normal host. Medicine (Baltimore) (1985) 2.34
The side effects of FK 506 in humans. Transplant Proc (1990) 2.08
Virus infections after transplantation in man. Brief review. Arch Virol (1977) 1.70
Alternative cell line for virus isolation. J Clin Microbiol (1986) 1.65
Cytomegalovirus infection of the alimentary tract: a clinicopathological correlation. Am J Gastroenterol (1986) 1.51
Enhancement of mouse cytomegalovirus infection during host-versus-graft reaction. Science (1975) 1.40
Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Surg Gynecol Obstet (1988) 1.38
Infections with FK 506 immunosuppression: preliminary results with primary therapy. Transplant Proc (1990) 1.30
A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Ann Surg (1985) 1.15
Studies on FK506 in experimental organ transplantation. Transplant Proc (1988) 1.10
Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants. Surgery (1981) 1.08
Transmission of cytomegalovirus infection with renal allograft. Kidney Int (1975) 1.08
Clinical development of Orthoclone OKT3. Transplant Proc (1987) 1.05
Gastrointestinal cytomegalovirus infection in heart and heart-lung transplant recipients. Arch Intern Med (1989) 1.04
Letter: Cytomegalovirus mononucleosis with severe thrombocytopenia. Ann Intern Med (1973) 1.02
Cytomegalovirus inclusions in the gastroduodenal mucosa of patients after renal transplantation. Gut (1981) 1.00
Specific cell-mediated immunity and infections with herpes viruses in cardiac transplant recipients. Am J Med (1982) 0.98
Impact of OKT3 Therapy on Cytomegalovirus and Herpes Simplex Virus Infections After Liver Transplantation. Transplant Proc (1988) 0.97
Seropositivity in liver transplant recipients as a predictor of cytomegalovirus disease. J Infect Dis (1988) 0.89
Incidence of cytomegalovirus infection and its relationship to donor-recipient serologic status in liver transplantation. Transplant Proc (1987) 0.88
Liver transplantation at the Mayo Clinic. Mayo Clin Proc (1986) 0.86
Syndromes of cytomegalovirus infection. Adv Intern Med (1980) 0.85
Infection in marrow transplantation: problems and perspectives. Transplant Proc (1978) 0.85
Gastric cytomegalic inclusion bodies diagnosed by histologic examination of endoscopic biopsies in patients with gastric ulcer. Am J Clin Pathol (1983) 0.84
Incidence of cytomegalovirus infection and effects of cytomegalovirus immune globulin prophylaxis after orthotopic liver transplantation. Transplant Proc (1987) 0.82
Gastric cytomegalovirus infection in bone marrow transplant patients: an indication of generalized disease. Cancer (1981) 0.81
Cytomegalovirus infection in orthotopic liver transplantation. Transpl Int (1989) 0.79
FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70
Kidney transplantation under FK 506. JAMA (1990) 7.45
The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89
Algebraic reconstruction techniques (ART) for three-dimensional electron microscopy and x-ray photography. J Theor Biol (1970) 6.86
Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features. Ann Intern Med (1984) 6.54
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96
IMMUNOSUPPRESSION WITH FR 900506 FOR CANINE KIDNEY AND LIVER TRANSPLANTATION. Surg Res Commun (1987) 4.68
Liver transplantation (1). N Engl J Med (1989) 4.53
Baboon-to-human liver transplantation. Lancet (1993) 4.01
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION. Surg Res Commun (1987) 3.46
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01
Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95
Liver transplantation (2). N Engl J Med (1989) 2.93
Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91
Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients. Transplantation (1986) 2.82
Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat Genet (1997) 2.81
Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75
THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS. Surg Res Commun (1987) 2.75
Different training procedures recruit either one or two critical periods for contextual memory consolidation, each of which requires protein synthesis and PKA. Learn Mem (1999) 2.72
Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. Lancet (1990) 2.66
The prognostic value of kidney transplant center report cards. Am J Transplant (2013) 2.64
Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc (1991) 2.59
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49
Hepatotrophic effects of FK506 in dogs. Transplantation (1991) 2.39
Prioritization and organ distribution for liver transplantation. JAMA (1994) 2.38
Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res (1996) 2.37
The effects of FK 506 on renal function after liver transplantation. Transplant Proc (1990) 2.31
FK 506 in clinical kidney transplantation. Transplant Proc (1991) 2.29
Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med (1993) 2.29
Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med (1997) 2.17
Left hepatic trisegmentectomy. Surg Gynecol Obstet (1982) 2.16
Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506. Transplant Proc (1990) 2.15
FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. Transplantation (1990) 2.13
Morphometric and electron-microscopic analyses of the effects of gonadotropin-releasing hormone agonists on uterine leiomyomas. Arch Pathol Lab Med (1998) 2.11
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc (1991) 2.10
Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res (2000) 2.04
Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol (2001) 2.04
Pathology of human intestinal transplantation. Gastroenterology (1996) 1.98
Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet (1995) 1.96
Role of murein lipoprotein in morphogenesis of the bacterial division septum: phenotypic similarity of lkyD and lpo mutants. J Bacteriol (1978) 1.94
Micromethods for induction and assay of mouse mixed lymphocyte reactions and cytotoxicity. Eur J Immunol (1976) 1.90
Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg (1988) 1.89
Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma: results of a randomized controlled trial. Arch Surg (2000) 1.89
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. Am J Transplant (2012) 1.88
Logistics and technique for combined hepatic-intestinal retrieval. Ann Surg (1992) 1.85
The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation (1992) 1.83
Experience with liver and kidney allografts from non-heart-beating donors. Transplantation (1995) 1.83
p-Chlorophenylalanine-induced chemical manifestations of phenylketonuria in rats. Science (1967) 1.82
BICAV: a block-iterative parallel algorithm for sparse systems with pixel-related weighting. IEEE Trans Med Imaging (2001) 1.79
Outcome of preimplantation genetic diagnosis of translocations. Fertil Steril (2000) 1.78
Monitoring and treatment of intestinal allograft rejection in humans. Transplant Proc (1993) 1.78
Infections in adult liver transplant patients under FK 506 immunosuppression. Transplant Proc (1991) 1.75
Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts. Mol Cell (1999) 1.74
Small intestinal transplantation in humans with or without the colon. Transplantation (1994) 1.74
Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. Transplant Proc (1991) 1.69
CT in patients with scirrhous carcinoma of the GI tract: imaging findings and value for tumor detection and staging. AJR Am J Roentgenol (1995) 1.68
EMG responses to maintain stance during multidirectional surface translations. J Neurophysiol (1998) 1.67
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther (2001) 1.65
Cyclosporine A augments the regenerative response after partial hepatectomy in the rat. Transplant Proc (1988) 1.64
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther (1999) 1.63
Comparison of beta-adrenergic agents delivered by nebulizer vs metered dose inhaler with InspirEase in hospitalized asthmatic patients. Chest (1988) 1.62
Orthotopic liver transplantation for alcoholic liver disease. Hepatology (1990) 1.61
Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation (1988) 1.61
Liver transplantation for polycystic liver disease. Arch Surg (1990) 1.61
The question of FK 506 nephrotoxicity after liver transplantation. Transplant Proc (1991) 1.60
Weaning of immunosuppression in long-term liver transplant recipients. Transplantation (1995) 1.59
Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation (1995) 1.59
Increased synthesis of norepinephrine and epinephrine in the intact rat during exercise and exposure to cold. J Pharmacol Exp Ther (1966) 1.58
PCR primers for human chromosomes: reagents for the rapid analysis of somatic cell hybrids. Genomics (1991) 1.58
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc (1991) 1.56
Survival from primary breast cancer after routine clinical use of mammography. Breast J (2002) 1.56
Cyclosporine Monitoring and Pharmacokinetics in Pediatrie Liver Transplant Patients. Transplant Proc (1985) 1.55
Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant (2006) 1.55
Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study. Am J Transplant (2013) 1.54
Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation (2000) 1.53
Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology (1987) 1.53
Morphological monitoring of human small bowel allografts. Transplant Proc (1993) 1.52
The cellular defect in alpha 1-proteinase inhibitor (alpha 1-PI) deficiency is expressed in human monocytes and in Xenopus oocytes injected with human liver mRNA. Proc Natl Acad Sci U S A (1985) 1.51
Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. BJOG (2014) 1.49
Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells. Clin Cancer Res (1997) 1.47
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation (1992) 1.45
Orthotopic liver transplantation for alcoholic cirrhosis. JAMA (1988) 1.45
Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol (1997) 1.44
Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology (2000) 1.44
Intestinal transplantation at the University of Pittsburgh. Transplant Proc (1994) 1.42